The store will not work correctly when cookies are disabled.
4-(2-(6-ethyl-5-hydroxypyridin-2-yl)vinyl)benzene-1,2-diol
ID: ALA5199640
PubChem CID: 146681511
Max Phase: Preclinical
Molecular Formula: C15H15NO3
Molecular Weight: 257.29
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1nc(/C=C/c2ccc(O)c(O)c2)ccc1O
Standard InChI: InChI=1S/C15H15NO3/c1-2-12-13(17)8-6-11(16-12)5-3-10-4-7-14(18)15(19)9-10/h3-9,17-19H,2H2,1H3/b5-3+
Standard InChI Key: UXKRAHDTHMACIN-HWKANZROSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-2.4986 1.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7840 1.8557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0721 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0721 0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7822 0.2069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4986 0.6149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3570 0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0717 0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7865 0.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 0.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 -0.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7883 -1.0308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0717 -0.6226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2132 -1.0315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7883 -1.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2132 0.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2132 -0.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2132 1.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 2 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
12 15 1 0
13 16 1 0
6 17 1 0
17 18 1 0
1 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 257.29 | Molecular Weight (Monoisotopic): 257.1052 | AlogP: 2.93 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.47 | CX Basic pKa: 5.33 | CX LogP: 3.25 | CX LogD: 3.21 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.74 | Np Likeness Score: 0.17 |
References
1. Fantacuzzi M, Amoroso R, Carradori S, De Filippis B.. (2022) Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy., 233 [PMID:35276424] [10.1016/j.ejmech.2022.114242] |